Zobrazeno 1 - 10
of 25
pro vyhledávání: '"James D. Dunbar"'
Autor:
Amy A Worth, Rosemary Shoop, Katie Tye, Claire H Feetham, Giuseppe D'Agostino, Garron T Dodd, Frank Reimann, Fiona M Gribble, Emily C Beebe, James D Dunbar, Jesline T Alexander-Chacko, Dana K Sindelar, Tamer Coskun, Paul J Emmerson, Simon M Luckman
Publikováno v:
eLife, Vol 9 (2020)
The cytokine, GDF15, is produced in pathological states which cause cellular stress, including cancer. When over expressed, it causes dramatic weight reduction, suggesting a role in disease-related anorexia. Here, we demonstrate that the GDF15 recept
Externí odkaz:
https://doaj.org/article/825a4f2bc81540a88d659e35ab6f5327
Autor:
Bingfa Sun, Francis S. Willard, Dan Feng, Jorge Alsina-Fernandez, Qi Chen, Michal Vieth, Joseph D. Ho, Aaron D. Showalter, Cynthia Stutsman, Liyun Ding, Todd M. Suter, James D. Dunbar, John W. Carpenter, Faiz Ahmad Mohammed, Eitaro Aihara, Robert A. Brown, Ana B. Bueno, Paul J. Emmerson, Julie S. Moyers, Tong Sun Kobilka, Matthew P. Coghlan, Brian K. Kobilka, Kyle W. Sloop
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 119(13)
Significance Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), which are incretin receptors that regulate carbohydrate metabolism. This investigational
Autor:
Olivier Benichou, Tamer Coskun, Malgorzata D. Gonciarz, Parag Garhyan, Andrew C. Adams, Yu Du, James D. Dunbar, Jennifer A. Martin, Kieren J. Mather, Richard T. Pickard, Vincent L. Reynolds, Deborah A. Robins, Simbarashe P. Zvada, Paul J. Emmerson
Publikováno v:
Cell Metabolism. 35:274-286.e10
Autor:
Alexei Kharitonenkov, John M Beals, Radmila Micanovic, Beth A Strifler, Radhakrishnan Rathnachalam, Victor J Wroblewski, Shun Li, Anja Koester, Amy M Ford, Tamer Coskun, James D Dunbar, Christine C Cheng, Christopher C Frye, Thomas F Bumol, David E Moller
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58575 (2013)
Fibroblast growth factor 21 is a novel hormonal regulator with the potential to treat a broad variety of metabolic abnormalities, such as type 2 diabetes, obesity, hepatic steatosis, and cardiovascular disease. Human recombinant wild type FGF21 (FGF2
Externí odkaz:
https://doaj.org/article/5847a90134ee450d8853ad80dc8fbeb7
Autor:
Tamer Coskun, Claire H. Feetham, Giuseppe D'Agostino, Garron T. Dodd, Amy A. Worth, Frank Reimann, James D. Dunbar, Fiona M. Gribble, Simon M. Luckman, Paul J. Emmerson, Katie Tye, Emily C Beebe, Dana Sindelar, Jesline T. Alexander-Chacko, Rosemary Shoop
Publikováno v:
Worth, A A, Shoop, R, Tye, K, Feetham, C H, D'Agostino, G, Dodd, G T, Reimann, F, Gribble, F M, Beebe, E C, Dunbar, J D, Alexander-Chacko, J T, Sindelar, D K, Coskun, T, Emmerson, P J & Luckman, S M 2020, ' The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling ', eLife, vol. 9, e55164, pp. 1-19 . https://doi.org/10.7554/eLife.55164
eLife, Vol 9 (2020)
eLife
eLife, Vol 9 (2020)
eLife
The cytokine, GDF15, is produced in pathological states which cause cellular stress, including cancer. When over expressed, it causes dramatic weight reduction, suggesting a role in disease-related anorexia. Here, we demonstrate that the GDF15 recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c36fee4c12ae9aa6d1944526e39affe
Autor:
Katie Tye, Fiona M. Gribble, Amy A. Worth, Paul J. Emmerson, Jesline T. Alexander-Chacko, Tamer Coskun, Emily C Beebe, James D. Dunbar, Rosemary Shoop, Giuseppe D'Agostino, Dana Sindelar, Garron T. Dodd, Claire H. Feetham, Frank Reimann, Simon M. Luckman
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39f2c4a0835c256636a335614171e764
https://doi.org/10.7554/elife.55164.sa2
https://doi.org/10.7554/elife.55164.sa2
Autor:
Andrew C Adams, Tamer Coskun, Armando R Irizarry Rovira, Michael A Schneider, David W Raches, Radmila Micanovic, Holly A Bina, James D Dunbar, Alexei Kharitonenkov
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e38438 (2012)
Fibroblast growth factors 19 (FGF19) and 21 (FGF21) have emerged as key regulators of energy metabolism. Several studies have been conducted to understand the mechanism of FGF19 and FGF21 action, however, the data presented has often been inconsisten
Externí odkaz:
https://doaj.org/article/83545c5b932f44aa84d465c8ea358ac7
Autor:
James D. Dunbar, Ricardo J. Samms, Francis J. P. Ebling, Dennis P. Smith, Jo E. Lewis, Paul J. Emmerson, Alan C. Perkins, Scott Cooper, Jeni Luckett, Andrew C. Adams, Kostas Tsintzas
Publikováno v:
Endocrinology
The increased prevalence of obesity and its cardiometabolic implications demonstrates the imperative to identify novel therapeutic targets able to effect meaningful metabolic changes in this population. Antibody-mediated targeting of fibroblast growt
Autor:
James D. Dunbar, Robert S. Warren, Mark W. Jackson, Gretchen A. LaRusch, Lindsey D. Mayo, David B. Donner
Publikováno v:
Cancer Research. 67:450-454
Hdm2 is elevated in numerous types of malignancies and is thought to impede the function of wild-type p53. Reactivation of p53 by disrupting the association with Hdm2 was the impetus for the development of Nutlin3. Although regulation of p53 has been
Autor:
Lindsey D. Mayo, Kelly M. Kessler, Li Wha Wu, David B. Donner, Robert S. Warren, Osman N. Ozes, James D. Dunbar
Publikováno v:
Journal of Biological Chemistry. 275:6059-6062
A protein that binds the intracellular domain of KDR (KDR-IC), a receptor for vascular endothelial cell growth factor (VEGF), was identified by two-hybrid screening. Two-hybrid mapping showed that the VEGF receptor-associated protein (VRAP) interacte